Stocklytics Platform
Asset logo for symbol AMED
Amedisys
AMED55
$90.90arrow_drop_up0.15%$0.14
Asset logo for symbol AMED
AMED55

$90.90

arrow_drop_up0.15%
Key Stats
Open$90.50
Prev. Close$90.79
EPS2.52
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range87.14
93.82
52 Week Range81.50
98.95
Ratios
EPS2.52
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

AMED-
US Healthcare Sector-
US Market-
warning

AMED / Market

AMED lose to the US Market which returned 273.57% over the last twenty four hours.
warning

AMED / Healthcare Sector

AMED lose to the US Healthcare sector which returned 3.42% over the last twenty four hours.

Amedisys (AMED) Statistics

Amedisys Inc (AMED) is a healthcare company that provides home health, hospice, and personal care services to patients in the United States. The company operates through three segments: Home Health, Hospice, and Personal Care. As of December 31, 2020, it owned and operated 506 Medicare-certified agencies and 119 hospice care centers. Amedisys Inc was founded in 1982 and is headquartered in Baton Rouge, Louisiana.
When it comes to stock statistics, Amedisys Inc has displayed strong performance. As of the latest data, the stock has a market capitalization of $982.84 million and a price-to-earnings ratio of 36.41. The company's stock has a beta of 1.60, indicating that it is more volatile compared to the overall market. Over the past year, Amedisys Inc stock has outperformed the sector by delivering a return of 49.23%, while the sector had a return of 32.14% during the same period.
add Amedisys  to watchlist

Keep an eye on Amedisys

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Amedisys (AMED) stock's performance compared to its sector and the market over the past year?

Over the past year, Amedisys (AMED) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.26%, Amedisys has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 43.70%, it has fallen short of the market average. This comparison highlights Amedisys 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Amedisys (AMED) stock?

The PE (Price to Earnings) ratio of Amedisys (AMED) is currently 36.07. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Amedisys (AMED) stock?

The Earnings Per Share (EPS) for Amedisys (AMED), calculated on a diluted basis, is $2.52. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Amedisys (AMED) stock?

The operating margin for Amedisys (AMED) is 8%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Amedisys (AMED) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Amedisys (AMED) is $286.93M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Amedisys (AMED) have?

Amedisys (AMED) has a total debt of $467.67M. The net debt, which accounts for cash and cash equivalents against the total debt, is $222.22M.

Take Your Investments to a Whole New Level